ARCHIVES

FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer

This article is from The Cancer Letter archive.

Vol. 21 No. 40 | October 20, 1995

Download PDF Visit The Full Archive

Related Articles

Foundation Issues Call For Tobacco Policy Research Proposals

November 27, 1992

NIH Recovery Act Announcements

March 27, 2009

Continuing Resolution Expires March 27; NIH, NCI Hope For Budget Compromise

March 15, 2013

President’s FY 1987 Budget Trims NCI 473 Million From 1986 Appropriation; Basic Research Hit Hard

February 7, 1986

FDA Approves Abbott’s HER-2 DNA Probe Kit.

January 25, 2002

Highlights of NCDDGs: 3 Drugs on Market, 12 in Development; Advisors Approve Plan to Issue $10.5 Million Contract For Pediatric Preclinical Testing Program

November 29, 2002